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Abstract 
 
 
 
 
 
 
 
Three newly synthesized benzamides by the Department of Pharmaceutical 
Chemistry of the Faculty of pharmacy from the University of Medicine and 
Pharmacy „Carol Davila” Bucharest were tested in order to determine whether these 
new molecules have similar effects on the central nervous system as those already in 
therapeutic use belonging to the same chemical group, such as tiapride (neuroleptic) 
or lidocaine (local anaesthetic).  
Tests were carried out on NMRI mice which were given new compounds, 
conventionally named I5C, I14C, and II5C in a dose of 1/20 of the lethal dose 50% 
(LD50), as previously determined. They received this treatment daily for 21 days. 
The evasive–investigating capacity of mice was determined using the platform test, 
and the motor activity using an Activity cage device.  
The results have shown that compounds I5C and II5C decrease the investigation 
capacity of the mice; and compound I5C inhibits motor activity, while II5C 
stimulates it. Thus we concluded that only compounds I5C and II5C have a 
neuroleptic potential that might be investigated further. 
 
 
Acn  onglobata is a rare, severe form of acne vulgaris characterized by the presence of comedones, 
papules, pustules, nodules and sometimes hematic or meliceric crusts, located on the face, trunk, neck, arms 
and buttocks.  
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Introduction 
Benzamides correspond to a carbonic acid amide of 
the benzoic acid. Amide has the general formula RCO-
NH2, in such compounds the carbon atom being 
attached to oxygen and also a hydroxyl group. 
Generally, amides are divided into distinct subclasses 
according to the number of nitrogen substituents. 
Primary amide results through NH2 replacement of the 
carboxylic hydroxyl group, and usually it has a higher 
boiling point than secondary and tertiary amides. The 
secondary and tertiary amides result when one or both 
hydrogens are replaced by other groups in primary 
amides (1-3). 
From the group of benzamides, two active 
substances have been extensively in use in psychiatry 
and other related medical fields, namely Sulpiride and 
Amisulpiride. Remoxipride is another benzamide that 
was removed from the market due to life threatening side 
effects in 1993 (4-6). Depending on the compound, 
benzamides have antidepressant activity, anticonvulsant 
activity, anti-inflammatory activity, analgesic properties, 
serotonin (5-HT) activity, antitumor activity, and 
antimicrobial activity (7-8). 
The purpose of this study was to identify new 
molecules with a higher degree of selectivity on 
receptors implicated in neurotransmission that is directly 
involved in the normal psychological functions, but with 
a lower rate of side effects. 
 
Materials and Methods 
 
A sample of 80 white NMRI mice having reached 
maturity, weighing 23±2g, divided in 4 groups, was used 
in this study. They were treated for 21 days as follows. 
Group 1 – I5C: 9,82mg/bw (1/20 x LD50) 
intraperitoneal injection 
Group 2 – I14C: 10,7mg/bw (1/20 x LD50) 
intraperitoneal injection 
Group 3 – II5C: 7,83mg/bw (1/20 x LD50) 
intraperitoneal injection 
Group 4 – Control: distilled water in similar 
injection volume. 
Mice were kept in an environment with constant 
temperature and relative humidity (22-24oC, 45-60%), 
while having free access to food and water. The 
chemical structures of the tested compounds are shown 
below (2): 
CO    N    (CH2)2    NH(C2H5)2
+
Cl-
Cl
Br
 
Figure 1. Chemical structure of compound I5C 
CO    N    (CH2)2    NH(C2H5)2
+
Cl-
Cl
H3CO
H3CO
H3CO
 
Figure 2. Chemical structure of compound I14C 
CO    N    (CH2)2    NH(CH3)2
+
Cl-
Cl
Br
 
Figure 3. Chemical structure of compound II5C 
 Testing investigation–evasion capacity (7). 
Each mouse was placed at the center of a circular 
platform 20cm in diameter with 2cm high margins 
suspended at a 50cm height from the horizontal surface 
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of a table. The number of times the mouse popped its 
head over the margins of the platform in a one minute 
time frame was recorded. This test was carried out on 
days 3, 7, 14, 21 of the experiment.   
 
 Testing motor activity (7). 
Each mouse was placed in an Autotrackactometer 
for 1 minute and three parameters were determined: the 
distance traveled by the mouse (m), the speed of 
traveling (m/s), and the time spent in the central area of 
observation (s). This test was carried out on days 4, 9, 
15, 22 of the experiment.  
All experimental procedures were carried out in 
accordance with the Directive 2010/63/UE of 22nd 
September 2010, regarding the protection of animals 
used for experimental and other scientific 
 
purposes. All experimental procedures were approved by 
the Ethical Committee of the Faculty of Pharmacy 
Bucharest.   
 
 Statistical analysis 
Statistical calculation used the software GraphPad 
Prism 5. Statistical comparison between groups used the 
Student t test (for normal distribution) for two groups. 
Normality of response distribution in collectivity was 
tested with the D’Agostino & Pearson test. Figures were 
made using a Microsoft Office Excel 2013 computer 
program. 
 
Results 
The evasion–investigation test yielded the following 
results:
 
Table 1. Dynamics of mouse crossings over the side of the platform 
 
Group/ Day of 
determination 
Average ± Standard 
deviation 
D`Agostino 
normality test 
Effect % vs 
Control 
t test vs Control  
(p value) 
Control – D3 6.05 ± 4.45 YES - - 
Control – D7 4.66 ± 2.93 YES - - 
Control – D14 5.80 ± 3.00 YES - - 
Control – D21 10.85 ± 5.17 YES - - 
I5C – D3 4.50 ± 2.11 YES -25.62% p>0.05 
I5C – D7 4.65 ± 2.77 YES -3.58% p>0.05 
I5C – D14 6.20 ± 3.10 YES +6.9% p>0.05 
I5C – D21 5.95 ± 3.12 YES -45.16% p<0.001 
I14C – D3 6.40 ± 2.87 YES +5.78% p>0.05 
I14C – D7 4.55 ± 3.56 YES -2.51% p>0.05 
I14C – D14 5.65 ± 3.71 YES -2.59% p>0.05 
I14C – D21 7.95 ± 4.44 YES -26.73% p>0.05 
II5C – D3 5.50 ± 3.31 YES -9.09% p>0.05 
II5C – D7 6.00 ± 3.65 YES +28.56% p>0.05 
II5C – D14 6.15 ± 3.77 YES +6.03% p>0.05 
II5C – D21 5.90 ± 4.46 YES -45.62% p<0.01 
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Figure 4. Effect dynamics of 3 benzamides over the 
course of the experiment versus Control in the 
investigation-evasion test 
Figure 5. Travelled distance dynamics inside the 
actometer over the course of the experiment 
versus Control conditions 
      Compounds I5C and II5C proved to have a negative 
impact on the evasion–investigation capacity of mice, 
especially after long term exposure when results became 
 
statistically significant. The motor activity test 
yielded the following results: 
 
Table 2. Evolution of the average travelled distance (measured in meters) inside the actometer 
Group/ Day of 
determination 
Average ± 
Standard 
deviation 
D`Agostino 
normality test 
Effect % vs 
Control 
t test vs Control 
(p value) 
Control – D4 6.42 ± 0.93 YES - - 
Control – D9 6.60 ± 1.83 YES - - 
Control – D15 5.91 ± 1.11 YES - - 
Control – D22 6.60 ± 1.22 YES - - 
I5C – D4 5.68 ± 0.85 YES -11.45% p<0.01 
I5C – D9 6.14 ± 0.44 YES -7.01% p>0.05 
I5C – D15 5.83 ± 0.99 YES -1.35% p>0.05 
I5C – D22 5.82 ± 1.29 YES -11.82% p<0.05 
I14C – D4 6.31 ± 1.01 YES -1.64% p>0.05 
I14C – D9 6.57 ± 0.75 YES -0.44% p>0.05 
I14C – D15 5.71 ± 1.43 YES -3.35% p>0.05 
I14C – D22 6.45 ± 0.80 YES -2.27% p>0.05 
II5C – D4 11.0 ± 3.57 YES +71.34% p<0.0001 
II5C – D9 6.32 ± 0.74 YES -4.36% p>0.05 
II5C – D15 6.30 ± 0.94 YES +6.7% p>0.05 
II5C – D22 7.77 ± 1.41 YES +17.76% p<0.05 
New synthesized benzamides on central nervous system  
152 
 
 
  
Table 3. Evolution of the average traveled speed (measured in meters/second) inside the actometer 
Group/ Day of 
determination 
Average ± Standard 
deviation 
D`Agostino 
normality 
test 
Effect % vs 
Control 
t test vs Control  
(p value) 
Control – D4 0.11 ± 0.02 YES - - 
Control – D9 0.11 ± 0.03 YES - - 
Control – D15 0.10 ± 0.02 YES - - 
Control – D22 0.11 ± 0.02 YES - - 
I5C – D4 0.09 ± 0.01 YES -12.78% p<0.05 
I5C – D9 0.10 ± 0.01 YES -9.15% p>0.05 
I5C – D15 0.10 ± 0.01 YES +0.39% p>0.05 
I5C – D22 0.10 ± 0.02 YES -12.31% p<0.05 
I14C – D4 0.11 ± 0.02 YES -2.55% p>0.05 
I14C – D9 0.12 ± 0.01 YES -1.44% p>0.05 
I14C – D15 0.10 ± 0.03 YES -2.22% p>0.05 
I14C – D22 0.11 ± 0.01 YES -1.97% p>0.05 
II5C – D4 0.19 ± 0.06 YES +73.18% p<0.001 
II5C – D9 0.11 ± 0.01 YES -6.36% p>0.05 
II5C – D15 0.11 ± 0.01 YES +8.42% p>0.05 
II5C – D22 0.14 ± 0.03 YES +17.52% p<0.05 
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Table 4. Evolution of the average time (measured in seconds) spent in the center of the actometer 
Group/ Day of determination 
Average ± 
Standard 
deviation 
D`Agostino 
normality 
test 
Effect % 
vs. 
Control 
t test vs 
Control 
(p value) 
Control – D4 12.51 ± 3.77 YES - - 
Control – D9 12.35 ± 3.18 YES - - 
Control – D15 10.29 ± 3.71 YES - - 
Control – D22 8.81 ± 3.27 YES - - 
I5C – D4 10.31 ± 3.12 YES -17.59% p<0.05 
I5C – D9 10.33 ± 3.36 YES -16.36% p>0.05 
I5C – D15 8.97 ± 3.50 YES -12.78% p>0.05 
I5C – D22 7.62 ± 4.89 YES -13.51% p>0.05 
I14C – D4 12.03 ± 3.36 YES -3.84% p>0.05 
I14C – D9 10.35 ± 2.80 YES -16.19% p<0.05 
I14C – D15 8.60 ± 3.16 YES -16.37% p>0.05 
I14C – D22 8.53 ± 3.89 YES -3.18% p>0.05 
II5C – D4 12.32 ± 3.61 YES -1.52% p>0.05 
II5C – D9 9.36 ± 2.43 YES -24.15% p<0.05 
II5C – D15 8.74 ± 2.95 YES -15.01% p>0.05 
II5C – D22 10.87 ± 3.13 YES 23.38% p<0.05 
     
Discussion 
Benzamides are a well known class of 
pharmacological agents with multiple uses in managing 
a wide range of nervous and psychic disorders. Tiapride, 
for instance, is used as an antipsychotic drug because it 
inhibits the D2 dopaminergic receptors, but it also has 
an indirect analgesic effect by activating the 5HT1 and 
5HT2 serotoninergic receptors (1-3). Sulpiride is 
another well-known example of an antipsychotic drug 
with a similar mechanism that is effective in the 
treatment of various forms of psychosis, but it also 
induces unpleasant side effects such as dizziness, 
headaches, tremor, dystonia, akathisia (4-6). 
The biological activities examined by several 
studies in organic scaffolds are therefore related to the 
pharmacological class of benzamides systems. Such 
biological activities are generally obtained through 
substitutions on benzamide either by the aliphatic, 
aromatic, or heteroaromatic path. In fact most 
substituted benzamides manifest bioactive properties, so 
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they should be viewed as possible medicinal 
compounds. 
In our study, compound II5C induced a statistically 
significant increase in motor activity (distance and 
speed) after 4 days of treatment (+71.34% and 
+73.14%) and after 22 days of treatment (+17.76% and 
+17.52%). 
Compound I5C induced a statistically significant 
decrease in motor activity (distance and speed) after 4 
days of treatment (-11.45% and -12.78%) and after 22 
days of treatment (-11.82% and -12.31%). 
After 9 days of treatment, compound II5C yielded a 
statistically significant decrease in the time spent in the 
central area of the actometer (-24.15%), but after 22 
days of treatment, the same compound resulted in a 
statistically significant increase of the same parameter 
(+23.38%), possibly a sign of anxiety decrease. 
Compound I5C yielded a decrease in the time spent 
in the central area of the actometer over the course of 
the experiment, but this was statistically significant only 
at the 4th day of the experiment.  
Conclusions 
The lack of effective treatment for many psychiatric 
diseases and the side effect complexity of many current 
drugs used for this purpose justify the need for medical 
research to find new alternatives (9).  
After performing two specific tests relevant for the 
normal functioning of the central nervous system, our 
findings revealed the following:  
Compounds I5C and II5C decreased in a 
statistically significant manner the evasion–
investigation capacity of mice (-45.16% and -45.62%), 
suggesting an intense central effect.  
Compound I5C induced a statistically significant 
decrease in motor activity, suggesting a sedative type of 
antipsychotic profile. 
Compound II5C induced a statistically significant 
increase in motor activity, suggesting a possible incisive 
type of neuroleptic profile. 
Further studies are necessary in order to confirm 
these preliminary findings. 
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